XAMSEHCS
Market cap75mUSD
Nov 18, Last price
9.10EUR
Name
European Healthcare Acquisition & Growth Company BV
Chart & Performance
Profile
European Healthcare Acquisition & Growth Company B.V. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more companies or businesses. It also focuses on acquiring companies or businesses in the healthcare sector with a focus on biotechnology and specialty pharma, pharma services, medical technology and medical devices, diagnostic and lab services, and bioinformatics, as well as life science tools subsectors in Europe. The company was incorporated in 2021 and is based in Munich, Germany.
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY |
---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | |
Income | |||
Revenues | |||
Cost of revenue | 1,244 | ||
Unusual Expense (Income) | |||
NOPBT | (1,244) | ||
NOPBT Margin | |||
Operating Taxes | 421 | (237) | |
Tax Rate | |||
NOPAT | (1,665) | 237 | |
Net income | (30,095) 1,091.41% | (2,526) | |
Dividends | |||
Dividend yield | |||
Proceeds from repurchase of equity | (190,800) | 1,205 | 211,619 |
BB yield | -1.82% | ||
Debt | |||
Debt current | |||
Long-term debt | |||
Deferred revenue | |||
Other long-term liabilities | |||
Net debt | (1,210) | (2,250) | (5,432) |
Cash flow | |||
Cash from operating activities | (1,952) | (3,189) | 588 |
CAPEX | |||
Cash from investing activities | |||
Cash from financing activities | (188,461) | (387) | 207,304 |
FCF | (227,880) | 225,524 | |
Balance | |||
Cash | 1,210 | 2,250 | 5,432 |
Long term investments | |||
Excess cash | 1,210 | 2,250 | 5,432 |
Stockholders' equity | (6,070) | (32,554) | (2,459) |
Invested Capital | 7,971 | 7,971 | 208,609 |
ROIC | 0.11% | ||
ROCE | 5.06% | ||
EV | |||
Common stock shares outstanding | 6,667 | 1,676 | |
Price | 10.00 0.50% | 9.95 | |
Market cap | 66,333 | ||
EV | 64,083 | ||
EBITDA | (1,244) | ||
EV/EBITDA | |||
Interest | 6,877 | 844 | |
Interest/NOPBT |